Real-time enrollment status for this atopic dermatitis (ad) clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 11:26 AM UTC
| NCT Number | NCT06982352 |
| Recruiting Status | Recruiting |
| Condition | Atopic Dermatitis (AD) |
| Phase | PHASE1 |
| Target Enrollment | 48 participants |
| Active Locations | 2 sites in the US |
| Sponsor | LAPIX Therapeutics Inc. |
| Last Updated on CT.gov | December 19, 2025 (Dec 19, 2025) |
As of August 28, 2026: Clinical trial NCT06982352 is currently recruiting participants. This phase1 study for atopic dermatitis (ad) is actively seeking new participants at 2 locations across the United States. The study is sponsored by LAPIX Therapeutics Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06982352 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06982352 was last updated Dec 19, 2025 (December 19, 2025). HelloStudys verifies this status automatically.